Online citations, reference lists, and bibliographies.
← Back to Search

Lipid-drug Conjugates: A Potential Nanocarrier System For Oral Drug Delivery Applications

S. Banerjee, A. Kundu
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
AbstractHydrophilic drugs are preferred candidates for most routes of drug administration, because of their enhanced solubility and dissolution under aqueous in vivo conditions. However, their hydrophilic nature also leads to decreased permeability across hydrophobic barriers. This is a severe limitation in situations where membrane permeability is the primary factor affecting bioavailability and efficacy of the drug. Highly impermeable cellular membranes or the tight endothelial junctions governing the blood-brain barrier are prime examples of this limitation. In other cases, decreased permeability across mucosal or epithelial membranes may require increased doses, which is an inefficient and potentially dangerous workaround. Covalent conjugation of hydrophilic drugs to hydrophobic moieties like short-chain lipids is a promising strategy for maintaining the critical balance between drug solubility and permeability. This article practically focuses on the production procedure of Lipid drug conjugates (LDCs), various formulation methodologies for preparing LDC nanoparticles with detailed about their in vitro physicochemical characterization at laboratory scale. Moreover, brief overviews on the role of LDCs in novel drug delivery applications as a substrate to various disease therapies are provided. Graphical AbstractThree dimensional (3-D) schematic representation of LDCs structures.
This paper references
10.1016/S0378-5173(98)00092-1
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions
C. Freitas (1998)
10.1002/EJLT.200300880
Determination of the fatty acid profile by 1H‐NMR spectroscopy
G. Knothe (2004)
10.2147/IJN.S3938
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
B. Mukherjee (2008)
10.1002/jps.21549
Experimental design for the optimization of lipid nanoparticles.
J. Zhang (2009)
10.1016/J.SUSC.2003.09.018
Preparation and characterization of an ultrahydrophobic surface based on a stearic acid self-assembled monolayer over polyethyleneimine thin films
Sili Ren (2003)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.1002/JPS.2600501018
Rate of release of medicaments from ointment bases containing drugs in suspension.
T. Higuchi (1961)
10.1016/B978-0-323-47347-7.00011-2
Lipid Nanoparticle Formulations for Enhanced Antituberculosis Therapy
S. Banerjee (2016)
Lipid Nanoparticle Formulations for Enhanced Anti-tuberculosis Therapy. Holban AM, Grumezescu AM. Nanoarchitectonics for Smart Delivery and Drug Targeting
S Banerjee (2016)
10.1080/03639040802130061
Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery.
M. Muchow (2008)
10.1021/mp200109m
Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation.
Rishi Paliwal (2011)
10.1016/J.COLSURFA.2012.02.013
Membrane affinity of antituberculotic drug conjugate using lipid monolayer containing mycolic acid
Cs. B. Pénzes (2012)
10.1016/S0928-0987(00)00161-5
Rationale and applications of lipids as prodrug carriers.
D. Lambert (2000)
10.1007/s002800050425
Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies
S. Sugarman (1996)
10.1021/LA062904P
Visualizing the structure of triglyceride nanoparticles in different crystal modifications.
H. Bunjes (2007)
10.1016/J.ADDR.2007.04.004
Stability of lipid excipients in solid lipid nanoparticles.
A. Radomska-Soukharev (2007)
10.1016/J.BMCL.2005.03.046
Synthesis and biological evaluation of gemcitabine-lipid conjugate (NEO6002).
S. Ali (2005)
10.1111/j.1745-7254.2008.00829.x
Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion
Zih-rou Huang (2008)
10.1016/S0378-5173(00)00378-1
Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.
V. Jenning (2000)
10.1002/ARDP.19933260810
Phenytoin‐Lipid Conjugates as Potential Prodrugs of Phenytoin
G. Scriba (1993)
Sterilization and physical stability of drug-free and etomidate- loaded solid lipid nanoparticles
C Schwarz (1995)
10.1016/S0939-6411(97)00107-0
NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.
S. Morel (1998)
10.1016/j.ijpharm.2012.05.033
Targeted lipid based drug conjugates: a novel strategy for drug delivery.
A. D. Vadlapudi (2012)
Determination of the fatty acid profile by 1HNMR spectroscopy
G Knothe (2004)
Polymer-stearic acid blends as form-stable phase change material for thermal energy storage
A. Sarı (2005)
10.1016/j.jconrel.2008.02.007
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
N. Anton (2008)
10.1080/1061186021000001832
Lipid-Drug-Conjugate (LDC) Nanoparticles as Novel Carrier System for the Hydrophilic Antitrypanosomal Drug Diminazenediaceturate
C. Olbrich (2002)
Conjugates for cancer therapy and diagnosis, patent application number
G Stela (2011)
10.1002/jps.22285
Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.
Ming-Jun Tsai (2011)
10.1166/JBN.2012.1464
Synthesis of cytarabine lipid drug conjugate for treatment of meningeal leukemia: development, characterization and in vitro cell line studies.
P. Sharma (2012)
10.1016/S0378-5173(99)00375-0
Evaluation of poly(2-hydroxyethyl methacrylate) gels as drug delivery systems at different pH values.
L. Ferreira (2000)
10.1016/j.carbpol.2013.01.028
Influence of process variables on essential oil microcapsule properties by carbohydrate polymer-protein blends.
Subham Banerjee (2013)
RECENT ADVANCEMENT OF LIPID DRUG CONJUGATE AS NANOPARTICULATE DRUG DELIV ERY SYSTEM
Ratna Jyoti Das (2013)
10.1021/BC00031A015
Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media.
N. Nakajima (1995)
TAKING POORLY WATER SOLUBLE COMPOUNDS THROUGH DISCOVERY
D. Wyatt (1999)
10.3109/08982100903161456
Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles
J. Varshosaz (2010)
10.1016/J.EJPB.2007.07.006
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
R. Mueller (2008)
10.1080/21691401.2018.1431648
Comparative study of oral lipid nanoparticle formulations (LNFs) for chemical stabilization of antitubercular drugs: physicochemical and cellular evaluation
S. Banerjee (2018)
10.1016/S0378-5173(02)00639-7
Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters.
P. Shahgaldian (2003)
10.1088/0957-4484/24/41/415102
Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies.
Y. R. Neupane (2013)
10.1002/mnfr.201000310
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
10.1080/02652040600612439
Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC
E. Souto (2006)
10.1002/JLAC.199419940709
Synthesis and oral uptake studies of lipidic and glyco-lipidic conjugates of β-lactam antibiotics
I. Toth (1994)
10.1007/S11051-009-9648-4
Enhanced gastrointestinal absorption of N3-O-toluyl-fluorouracil by cationic solid lipid nanoparticles
Donghua Liu (2010)
10.1208/s12249-010-9563-0
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
S. Das (2010)
10.1016/j.ijpharm.2010.12.038
Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.
M. G. Sarpietro (2011)
10.1080/10611860902718672
Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement
Baboota Sanjula (2009)
10.1023/A:1016042504830
Atomic Force Microscopy Studies of Solid Lipid Nanoparticles
A. Mühlen (2004)
10.1016/S0009-3084(00)00167-5
Drug-phospholipid conjugates as potential prodrugs: synthesis, characterization, and degradation by pancreatic phospholipase A(2).
M. Kurz (2000)
10.1201/9780203748572
Lymphatic Transport of Drugs
W. Charman (1992)
10.1016/S0378-5173(00)00639-6
The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles.
A. Gessner (2001)
10.5772/50486
Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development
A. Attama (2012)
10.1016/J.EJPB.2007.06.015
Lipid nanoparticles for alkyl lysophospholipid edelfosine encapsulation: development and in vitro characterization.
A. Estella-Hermoso de Mendoza (2008)
1-ピレン-カルボキシアルデヒドからのグラフェンオキシドの還元に基づく白金ナノ粒子の高分散に対するカルボン酸官能化グラフェンナノシートの合成 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター
Kuang Yinjie (2013)
Synthesis and biological evaluation of gemcitabine-lipid conjugate
SM Ali (2005)
S,GascoMR.NMR relaxometric investigations of lipid nanoparticles (SLN) containining gadolinium (III) complexes
S Morel (1998)
10.1016/S0928-0987(00)00062-2
Lipophilic methotrexate conjugates with antitumor activity.
R. Pignatello (2000)
Pharmacokinetic characteristics of the cytarabine prodrug, ilecytarabine, after intravenous and oral administration to rats
B. Wen (2008)
10.2147/IJN.S9962
Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation
B. Sahana (2010)
10.1016/j.nano.2008.08.003
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Rishi Paliwal (2009)
Conjugates for cancer therapy and diagnosis, patent application number: 20110275590
G Stela (2011)
10.1016/j.ijpharm.2010.02.014
Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin.
A. Dicko (2010)
10.1016/J.JCONREL.2004.02.024
Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.
C. Olbrich (2004)
10.2217/nnm.10.42
Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.
Shuyu Xie (2010)



This paper is referenced by
Lipid-based nanoparticles as novel drug delivery systems for antimicrobial agents
A. Rassouli (2019)
10.1016/j.yrtph.2020.104699
Yellow-colored extract from cashew byproduct - Nonclinical safety assessment.
Gisele Goulart da Silva (2020)
10.5772/INTECHOPEN.88412
Self-Emulsifying Drug Delivery Systems: Easy to Prepare Multifunctional Vectors for Efficient Oral Delivery
K. AboulFotouh (2019)
10.1021/acsomega.9b03523
Formulation and Intracellular Trafficking of Lipid–Drug Conjugate Nanoparticles Containing a Hydrophilic Antitubercular Drug for Improved Intracellular Delivery to Human Macrophages
Sayantan Pandit (2020)
10.1016/j.msec.2020.111279
Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate.
Aakriti Singh (2020)
10.1016/j.biomaterials.2019.119441
Synthesis of a long acting nanoformulated emtricitabine ProTide.
Dhruvkumar Soni (2019)
10.1080/17425255.2019.1621289
Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs
S. Banerjee (2019)
10.1016/j.cis.2019.07.005
Lipid-based nano delivery of antimicrobials to control food-borne bacteria.
M. Yousefi (2019)
10.1155/2019/8453493
Functional Graphene Oxide Nanocarriers for Drug Delivery
Yuanfeng Ye (2019)
10.1007/s40199-019-00277-0
Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay
M. Hajizadeh (2019)
10.1208/s12249-020-01772-3
Comparative Pharmacokinetics of Nimodipine in Rat Plasma and Tissues Following Intraocular, Intragastric, and Intravenous Administration
Fang Li (2020)
10.1080/10837450.2019.1694037
Lipid–drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery
Funanani Takalani (2019)
Semantic Scholar Logo Some data provided by SemanticScholar